FDA data Registry peer set 1 peer

Alternatives to suvorexant

1 same-class SPL records vs suvorexant - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Belsomra

Orexin Receptor Antagonist Prescription 1 alternative found

About suvorexant

Belsomra is a prescription medicine used to treat insomnia. It helps you fall asleep and stay asleep.

Used for: Belsomra is used to treat insomnia in adults. Insomnia means you have trouble falling asleep, staying asleep, or both. This medicine can help you sleep better.

1 Orexin Receptor Antagonist peers (wide set)

Compare suvorexant vs lemborexant side-by-side →

suvorexant vs lemborexant · FAERS reaction fields

FAERS top-reaction field "Nightmare" shows the widest count spread between suvorexant and lemborexant in this extract (662-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect suvorexant lemborexant
Nightmare 736 74
Somnolence 726 128
Insomnia 674 75
Abnormal Dreams 599 -
Headache 535 84
Feeling Abnormal 485 -
Nausea 381 80
Hallucination 372 -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

suvorexant peer mix vs class inventory

Peer mix

0 OTC and 1 Rx SPL records in this peer set (1 total). Class inventory for Orexin Receptor Antagonist: 2 drugs.

Frequently Asked Questions

What same-class SPL records sit beside suvorexant?
This registry lists 1 Orexin Receptor Antagonist medication records beside suvorexant, including lemborexant. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Orexin Receptor Antagonist peer set (1 records)

suvorexant (Belsomra) sits in a wide Orexin Receptor Antagonist peer set (1 of 1 class peers shown). Labeled indication field for suvorexant: Belsomra is used to treat insomnia in adults.

Top FAERS reaction fields for suvorexant total 5,186 reports across 10 reactions, set beside lemborexant. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full suvorexant profile →

Field note for suvorexant: see also the generic vs brand label guide when reading Belsomra SPL strings.